The rarest of all diseases are becoming treatable

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Teens may have come up with a new way to detect, treat Lyme disease using CRISPR gene editing

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

Computational framework streamlines therapeutic RNA nanocarrier design

A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...

Intellia Therapeutics: Critical Safety Updates Are Imminent - Expect Volatility

Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...

gRNA Market Size Worth USD 3,171.65 Million By 2034 Fueled by Rapid Expansion of Gene Editing Applications

According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...
Technology Networks

A New Platform Could Speed Up RNA Drug Design

Researchers developed Bits2Bonds, a platform that merges molecular dynamics simulations with machine learning to design new ...
News-Medical.Net on MSN

Designing better RNA delivery polymers with computational tools

A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
AlphaGalileo

Computational framework for therapeutic RNA carrier design

LMU Researchers Combine Machine Learning and Molecular Dynamics to Discover Novel RNA Delivery Materials. While experimental screening of polymer libraries is time-consuming and costly, purely ...

Medicine’s AI Evolution

Drug development in biotechnology takes time. A lot of time. On average, it takes 10 to 15 years to take a medicine from ...